FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2010/091/000228 [Registered on: 30/04/2010]
Last Modified On:
Post Graduate Thesis   
Type of Trial   
Type of Study    
Study Design  Other 
Public Title of Study   RISK OF SEIZURE RECURRENCE IN PATIENTS WITH NEW ONSET PARTIAL SEIZURE: A COMPARATIVE STUDY BETWEEN PATIENTS HAVING SOLITARY CYSTICERCUS GRANULOMA AND THOSE WITH NORMAL NEUROIMAGING 
Scientific Title of Study   RISK OF SEIZURE RECURRENCE IN PATIENTS WITH NEW ONSET PARTIAL SEIZURE: A COMPARATIVE STUDY BETWEEN PATIENTS HAVING SOLITARY CYSTICERCUS GRANULOMA AND THOSE WITH NORMAL NEUROIMAGING 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pawan Sharma 
Designation   
Affiliation   
Address  department of neurology
CSM Medical University
Lucknow
UTTAR PRADESH
226003
India 
Phone  05222257090  
Fax  05222257090  
Email  drpawan_sharma@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  prof R.K.GARG 
Designation   
Affiliation   
Address  department of neurology
CSM Medical University
Lucknow
UTTAR PRADESH
226003
India 
Phone  05222257090  
Fax  05222257090  
Email  garg50@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  prof R.K.GARG 
Designation   
Affiliation   
Address  Department of neurology
CSM Medical University
Lucknow
UTTAR PRADESH
226003
India 
Phone  05222257090  
Fax  05222257090  
Email  garg50@yahoo.com  
 
Source of Monetary or Material Support  
none 
none 
 
Primary Sponsor  
Name  none 
Address   
Type of Sponsor   
 
Details of Secondary Sponsor  
Name  Address 
none   
none   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof R.K GARG  Department of neurology  Department of neurology ,CSM MEDICAL UNIVERSITY-226003
Lucknow
UTTAR PRADESH 
05222257090
05222257090
garg50@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE,CSMMU,LUCKNOW  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  epilepsy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  not applicable  not applicable 
Comparator Agent  not applicable  not applicable 
 
Inclusion Criteria  
Age From   
Age To   
Gender   
Details  The patients of new onset partial seizure of <2 week duration with CECT brain showing solitary cystic granuloma or normal neuroimaging including MRI BRAIN WITH GAD 
 
ExclusionCriteria 
Details  the patientswho had received anticysticidal therapy such as albendazole or steroid. the patients fitting in benign epilepsy syndrome such as benign rolandic epilepsy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
seizure recurrence  6 month 
 
Secondary Outcome  
Outcome  TimePoints 
death   6 month 
 
Target Sample Size   Total Sample Size="82"
Sample Size from India="" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   Date Missing 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/11/2009 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Completed 
Recruitment Status of Trial (India)   
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   this is a prospective observational study of patients with new onset partial seizures.the patients having lesion fulfilling criteria of SCG (as defined by Rajshekhar et al) in CECT Brain and patients having normal neuroimaging (both CECT as well as MRI with GAD)will be followed for seizure recurrence for atleast 6 months.the risk of seizure recurrence will be compared in both the groups and predictors of seizure recurrence will be evaluated.  
Close